Key terms
About MNOV
MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. The company was founded by Yuichi Iwaki on September 26, 2000, and is headquartered in La Jolla, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MNOV news
Apr 01
4:25pm ET
MediciNova Vice President Geoffrey O’Brien Announces Retirement
Mar 26
7:01pm ET
MediciNova gets notice of allowance from Japan for pending patent for MN-166
Mar 20
7:13pm ET
MediciNova’s two abstrats regarding MN-001 and MN-002 accepted at EAS
Mar 12
6:35am ET
MediciNova’s MN-166 shows efficacy in lung injury study
Jan 17
6:02am ET
MediciNova receives Notice of Grant for new patent covering MN-166
No recent press releases are available for MNOV
MNOV Financials
Key terms
Ad Feedback
MNOV Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MNOV Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range